Silver Spike Investment Corp. (SSIC)
USD 10.74
(1.27%)
USD 10.74
(1.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -32.61 Million USD | 7.16% |
| 2022 | -35.12 Million USD | 58.56% |
| 2021 | -84.76 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -33.16 Million USD | -1.68% |
| 2023 FY | -32.61 Million USD | 7.16% |
| 2023 Q4 | -32.61 Million USD | -9.36% |
| 2023 Q3 | -29.82 Million USD | 9.35% |
| 2023 Q2 | -32.89 Million USD | -1.08% |
| 2023 Q1 | -32.54 Million USD | 7.35% |
| 2022 Q3 | -61.05 Million USD | -0.72% |
| 2022 FY | -35.12 Million USD | 58.56% |
| 2022 Q4 | -35.12 Million USD | 42.47% |
| 2022 Q2 | -60.61 Million USD | 28.49% |
| 2022 Q1 | -84.76 Million USD | 0.0% |
| 2021 Q2 | -5400.00 USD | 0.0% |
| 2021 FY | -84.76 Million USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | 1870.712% |
| Alpha Teknova, Inc. | 1.97 Million USD | 1752.059% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 134.617% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 143.511% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 107.491% |
| Cosmos Health Inc. | 8.59 Million USD | 479.613% |
| Journey Medical Corporation | -9.7 Million USD | -235.891% |
| Embecta Corp. | 1.31 Billion USD | 102.486% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 107.11% |
| Dynavax Technologies Corporation | 106.63 Million USD | 130.582% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 75.073% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 107.536% |
| PainReform Ltd. | -7.95 Million USD | -310.209% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -108.586% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -108.586% |
| SCYNEXIS, Inc. | -19.35 Million USD | -68.536% |
| Safety Shot Inc | -2.28 Million USD | -1327.596% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | -245.838% |
| Procaps Group, S.A. | 242.93 Million USD | 113.424% |
| Theratechnologies Inc. | 24.87 Million USD | 231.123% |
| Harrow Health, Inc. | 116.41 Million USD | 128.013% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -1194.113% |
| Biofrontera Inc. | 4.05 Million USD | 904.034% |
| DURECT Corporation | -7.65 Million USD | -326.073% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 2.73% |
| Cronos Group Inc. | -663.32 Million USD | 95.084% |
| OptiNose, Inc. | 58.06 Million USD | 156.164% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 105.231% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | -123.797% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -528.836% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 317.223% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | -412.79% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 30618.379% |
| Radius Health, Inc. | 359.28 Million USD | 109.077% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 16636.586% |
| ProPhase Labs, Inc. | 19.23 Million USD | 269.578% |
| Phibro Animal Health Corporation | 454.84 Million USD | 107.17% |
| Procaps Group S.A. | 242.93 Million USD | 113.424% |
| Alvotech | 1.06 Billion USD | 103.064% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 986.668% |
| Viatris Inc. | 17.13 Billion USD | 100.19% |
| Rockwell Medical, Inc. | 4.45 Million USD | 831.859% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -568.682% |
| SIGA Technologies, Inc. | -148.68 Million USD | 78.066% |
| Tilray Brands, Inc. | 158.97 Million USD | 120.513% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 126.753% |
| Shineco, Inc. | 29.29 Million USD | 211.339% |
| PetIQ, Inc. | 351.93 Million USD | 109.266% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -1023.986% |
| Incannex Healthcare Limited | -5.48 Million USD | -494.56% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 118.393% |
| Alimera Sciences, Inc. | 55.3 Million USD | 158.963% |
| Assertio Holdings, Inc. | -32.52 Million USD | -0.254% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -2090.579% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -544.45% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -577.433% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -297.05% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 873.337% |
| Hempacco Co., Inc. | 13.61 Million USD | 339.533% |
| Talphera, Inc. | -5.72 Million USD | -470.034% |
| Alvotech | 1.06 Billion USD | 103.064% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 556.426% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 66.279% |
| Currenc Group, Inc. | -16.57 Million USD | -96.774% |
| Kamada Ltd. | -46.43 Million USD | 29.764% |
| Indivior PLC | -33.95 Million USD | 3.948% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 12615.307% |
| Flora Growth Corp. | -713 Thousand USD | -4473.862% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -297.05% |
| Evolus, Inc. | 63.7 Million USD | 151.189% |
| HUTCHMED (China) Limited | -197.45 Million USD | 83.484% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 106.807% |
| Akanda Corp. | 3.9 Million USD | 935.143% |